Brightworth Amgen Inc Transaction History

Brightworth

$933 Million
Q3 2022

A detailed history of Brightworth transactions in Amgen Inc stock. As of the latest transaction made, Brightworth holds 4,133 shares of AMGN stock, worth $1.09 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,133

Previous 4,088 1.1%

Holding current value

$1.09 Million

Previous $995,000 6.33%

% of portfolio

0.1%

Previous 0.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $10,100 - $11,391	45 Added 1.1%	4,133 $932,000
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $7,613 - $8,472	-33 Reduced 0.8%	4,088 $995,000
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $4.51 Million - $4.99 Million	-20,586 Reduced 83.32%	4,121 $996,000
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $562,631 - $643,880	2,829 Added 12.93%	24,707 $5.56 Million
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $410,105 - $480,488	1,932 Added 9.69%	21,878 $4.65 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $708,915 - $786,489	3,035 Added 17.95%	19,946 $4.86 Million
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $445,373 - $519,010	2,007 Added 13.47%	16,911 $4.21 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $244,509 - $291,167	1,130 Added 8.2%	14,904 $3.43 Million
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $480,563 - $534,425	2,048 Added 17.47%	13,774 $3.5 Million
Q2 2020 Jul 22, 2020	BUY	$197.81 - $242.74 $454,765 - $558,059	2,299 Added 24.39%	11,726 $2.77 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $1.22 Million - $1.62 Million	6,687 Added 244.05%	9,427 $1.91 Million
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $12,939 - $17,160	-71 Reduced 2.53%	2,740 $661,000
Q4 2019 Jan 23, 2020	BUY	$189.21 - $243.2 $172,181 - $221,312	910 Added 47.87%	2,811 $678,000
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $32,210 - $38,594	185 Added 10.78%	1,901 $368,000
Q2 2019 Jul 31, 2019	BUY	$166.7 - $195.41 $44,508 - $52,174	267 Added 18.43%	1,716 $316,000
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $262,080 - $295,422	1,449 New	1,449 $275,000
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $338,077 - $379,734	-2,036 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $340,602 - $388,876	2,036	2,036 $380,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brightworth, based on Form 13F filings with the SEC.

News

Stay updated on Brightworth with notifications on news.

Account